Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

The role of the fibroblast growth factor family in bone-related diseases.

Wang J, Liu S, Li J, Yi Z.

Chem Biol Drug Des. 2019 Oct;94(4):1740-1749. doi: 10.1111/cbdd.13588. Epub 2019 Aug 4. Review.

PMID:
31260189
2.

Fibroblast Growth Factor 21 Is Associated With Bone Mineral Density, but not With Bone Turnover Markers and Fractures in Chinese Postmenopausal Women.

Hu W, He J, Fu W, Wang C, Yue H, Gu J, Zhang H, Zhang Z.

J Clin Densitom. 2019 Apr - Jun;22(2):179-184. doi: 10.1016/j.jocd.2018.08.005. Epub 2018 Aug 22.

PMID:
30228048
3.

Histone Deacetylase 3 Deletion in Mesenchymal Progenitor Cells Hinders Long Bone Development.

Feigenson M, Shull LC, Taylor EL, Camilleri ET, Riester SM, van Wijnen AJ, Bradley EW, Westendorf JJ.

J Bone Miner Res. 2017 Dec;32(12):2453-2465. doi: 10.1002/jbmr.3236. Epub 2017 Sep 18.

4.

Correlations of Cerebrospinal Fluid/Plasma Fibroblast Growth Factor 21 Ratio with Metabolic Parameters in Chinese Individuals of Normal Weight.

Li Q, Yu Y, Kang Y, Xu J, Lin H, Wang X, Pang L, Hu L, Zhang Y, Yang X, Zuo W, Qiu G, Jiang Y, Li C, Wang G.

Clin Lab. 2016;62(5):893-9.

PMID:
27349016
5.

Fibroblast growth factor-21 restores insulin sensitivity but induces aberrant bone microstructure in obese insulin-resistant rats.

Charoenphandhu N, Suntornsaratoon P, Krishnamra N, Sa-Nguanmoo P, Tanajak P, Wang X, Liang G, Li X, Jiang C, Chattipakorn N, Chattipakorn S.

J Bone Miner Metab. 2017 Mar;35(2):142-149. doi: 10.1007/s00774-016-0745-z. Epub 2016 Mar 29.

PMID:
27026433
6.

Serum FGF-21 levels are associated with worsened radial trabecular bone microarchitecture and decreased radial bone strength in women with anorexia nervosa.

Fazeli PK, Faje AT, Cross EJ, Lee H, Rosen CJ, Bouxsein ML, Klibanski A.

Bone. 2015 Aug;77:6-11. doi: 10.1016/j.bone.2015.04.001. Epub 2015 Apr 11.

7.

Interactions between FGF21 and BMP-2 in osteogenesis.

Ishida K, Haudenschild DR.

Biochem Biophys Res Commun. 2013 Mar 22;432(4):677-82. doi: 10.1016/j.bbrc.2013.02.019. Epub 2013 Feb 14.

PMID:
23416071
8.

From bench to bedside: novel mechanisms and therapeutic advances through the development of selective peroxisome proliferator-activated receptor gamma modulators.

Blackburn GL.

Am J Clin Nutr. 2010 Jan;91(1):251S-253S. doi: 10.3945/ajcn.2009.28449A. Epub 2009 Nov 18. Review.

PMID:
19923371

Supplemental Content

Loading ...
Support Center